Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib
Titel:
Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib
Auteur:
Cortes, Jorge E. Nicolini, Franck E. Wetzler, Meir Lipton, Jeffrey H. Akard, Luke Craig, Adam Nanda, Nisha Benichou, Annie-Claude Leonoudakis, Janis Khoury, H. Jean Hochhaus, Andreas Baccarani, Michele Kantarjian, Hagop M.